David C. Bupp

2011

In 2011, David C. Bupp earned a total compensation of $606.2K as President and Chief Executive Officer at Navidea Biopharmaceuticals, a 43% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$60,000
Salary$536,282
Other$9,967
Total$606,249

Bupp received $536.3K in salary, accounting for 88% of the total pay in 2011.

Bupp also received $60K in non-equity incentive plan and $10K in other compensation.

Rankings

In 2011, David C. Bupp's compensation ranked 7,451st out of 10,747 executives tracked by ExecPay. In other words, Bupp earned more than 30.7% of executives.

ClassificationRankingPercentile
All
7,451
out of 10,747
31st
Division
Manufacturing
2,730
out of 3,960
31st
Major group
Chemicals And Allied Products
675
out of 1,033
35th
Industry group
Drugs
472
out of 781
40th
Industry
In Vitro and In Vivo Diagnostic Substances
25
out of 43
42nd
Source: SEC filing on July 10, 2012.

Bupp's colleagues

We found five more compensation records of executives who worked with David C. Bupp at Navidea Biopharmaceuticals in 2011.

2011

Thomas Tulip

Navidea Biopharmaceuticals

President and Chief Business Officer

2011

Mark Pykett

Navidea Biopharmaceuticals

Chief Executive Officer

2011

Frederick Cope

Navidea Biopharmaceuticals

Chief Scientific Officer

2011

Brent Larson

Navidea Biopharmaceuticals

Chief Financial Officer

2011

Rodger Brown

Navidea Biopharmaceuticals

Vice President, Global Regulatory Operations and Quality Assurance

You may also like